BIO Key Ownership
| BKYI Stock | USD 1.06 0.05 4.95% |
BIO |
BIO Stock Ownership Analysis
The company recorded a loss per share of 8.66. BIO Key International last dividend was issued on the 20th of November 2020. The entity had 1:18 split on the 21st of December 2023. BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey. Bio-Key Intl operates under Security Protection Services classification in the United States and is traded on NASDAQ Exchange. It employs 51 people. For more info on BIO Key International please contact Michael DePasquale at 732 359 1100 or go to https://www.bio-key.com.Besides selling stocks to institutional investors, BIO Key also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different BIO Key's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align BIO Key's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
BIO Key Quarterly Liabilities And Stockholders Equity |
|
About 6.0% of BIO Key International are currently held by insiders. Unlike BIO Key's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against BIO Key's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of BIO Key's insider trades
BIO Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as BIO Key is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading BIO Key International backward and forwards among themselves. BIO Key's institutional investor refers to the entity that pools money to purchase BIO Key's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Goss Wealth Management Llc | 2024-12-31 | 4.0 | Wells Fargo & Co | 2024-12-31 | 3.0 | Northern Trust Investments N A | 2024-12-31 | 0.0 | Ubs Group Ag | 2024-12-31 | 0.0 | Abich Financial Wealth Management Llc | 2024-09-30 | 0.0 | Headlands Technologies Llc | 2024-12-31 | 0.0 | Armistice Capital, Llc | 2024-12-31 | 0.0 | Citadel Advisors Llc | 2024-12-31 | 20.3 K | Virtu Financial Llc | 2024-12-31 | 15.5 K | Geode Capital Management, Llc | 2024-12-31 | 11.2 K | Xtx Topco Ltd | 2024-12-31 | 10.2 K |
BIO Key International Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BIO Key insiders, such as employees or executives, is commonly permitted as long as it does not rely on BIO Key's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases BIO Key insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
BIO Key Outstanding Bonds
BIO Key issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. BIO Key International uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most BIO bonds can be classified according to their maturity, which is the date when BIO Key International has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BIOGEN INC 52 Corp BondUS09062XAD57 | View | |
| BIOGEN INC 405 Corp BondUS09062XAF06 | View | |
| BIOGEN INC Corp BondUS09062XAG88 | View | |
| BIOGEN INC Corp BondUS09062XAH61 | View |
Currently Active Assets on Macroaxis
When determining whether BIO Key International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BIO Key's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Key International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Key International Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Systems Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.66) | Revenue Per Share | Quarterly Revenue Growth (0.41) | Return On Assets | Return On Equity |
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.